A detailed history of Ostrum Asset Management transactions in Natera, Inc. stock. As of the latest transaction made, Ostrum Asset Management holds 981 shares of NTRA stock, worth $157,215. This represents 0.01% of its overall portfolio holdings.

Number of Shares
981
Previous 2,579 61.96%
Holding current value
$157,215
Previous $279 Million 55.41%
% of portfolio
0.01%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$97.75 - $129.67 $156,204 - $207,212
-1,598 Reduced 61.96%
981 $125 Million
Q2 2024

Aug 13, 2024

BUY
$85.28 - $112.6 $35,305 - $46,616
414 Added 19.12%
2,579 $279 Million
Q1 2024

May 13, 2024

BUY
$59.21 - $92.9 $65,663 - $103,026
1,109 Added 105.02%
2,165 $198 Million
Q4 2023

Feb 13, 2024

SELL
$37.55 - $62.64 $69,918 - $116,635
-1,862 Reduced 63.81%
1,056 $66.1 Million
Q3 2023

Nov 14, 2023

BUY
$43.4 - $62.52 $126,641 - $182,433
2,918 New
2,918 $129 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.5B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Ostrum Asset Management Portfolio

Follow Ostrum Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ostrum Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Ostrum Asset Management with notifications on news.